![Mary Tagliaferri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Tagliaferri
Direttore Tecnico/Scientifico/R&S presso
NEKTAR THERAPEUTICS
Profilo
Mary A. Tagliaferri was the founder of Bionovo, Inc., founded in 2002, where the titles held included President, Secretary, Treasurer & Director from 2011 to 2012.
Current jobs include Director at Iambic Therapeutics, Inc. starting in 2024 and Chief Medical Officer at Nektar Therapeutics starting in 2025.
Former jobs include Director at Atossa Therapeutics, Inc., Independent Director at Rayzebio, Inc. from 2021 to 2024, Independent Director at Enzo Biochem, Inc. from 2023 to 2024, Independent Director at Y-mAbs Therapeutics, Inc. from 2024 to 2025, Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc., and Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Education includes an undergraduate degree from Cornell University in 1988, a graduate degree from American College of Traditional Chinese Medicine in 1995, and a doctorate from The University of California, San Francisco in 2002.
Posizioni attive di Mary Tagliaferri
| Società | Posizione | Inizio |
|---|---|---|
| NEKTAR THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 01/09/2025 |
Entos, Inc.
 Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Direttore/Membro del Consiglio | 19/09/2024 |
Precedenti posizioni note di Mary Tagliaferri
| Società | Posizione | Fine |
|---|---|---|
| YMAS THER | Direttore/Membro del Consiglio | 11/07/2025 |
| ENZO BIOCHEM, INC. | Presidente | 25/10/2023 |
| RAYZEBIO, INC. | Direttore/Membro del Consiglio | 26/02/2024 |
Kanglaite USA, Inc.
 Kanglaite USA, Inc. Pharmaceuticals: MajorHealth Technology The private company is based in Redwood City, CA. Kanglaite USA, Inc. is a biotechnology company developing treatments for solid tumors and cancer-associated anorexia-cachexia syndrome. The company’s lead product, Kanglaite Injection (KLTi), has been approved in China for the treatment of advanced non-small cell lung cancer and hepatocellular cancer, and is currently under investigation in the United States for cancer-related indications. The company focuses on discovering and developing natural therapies for various cancers, including pancreatic and prostate cancer. | Direttore Tecnico/Scientifico/R&S | 01/06/2014 |
| BIONOVO INC. | Fondatore | 01/06/2012 |
Formazione di Mary Tagliaferri
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Lighten Up Enterprises International, Inc.
 Lighten Up Enterprises International, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Bionovo, Inc.
 Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals & drugs | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Traditional Chinese Medicine
 American College of Traditional Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Kanglaite USA, Inc.
Kanglaite USA, Inc. Pharmaceuticals: MajorHealth Technology The private company is based in Redwood City, CA. Kanglaite USA, Inc. is a biotechnology company developing treatments for solid tumors and cancer-associated anorexia-cachexia syndrome. The company’s lead product, Kanglaite Injection (KLTi), has been approved in China for the treatment of advanced non-small cell lung cancer and hepatocellular cancer, and is currently under investigation in the United States for cancer-related indications. The company focuses on discovering and developing natural therapies for various cancers, including pancreatic and prostate cancer. | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
